Pharmaceutical giant expects the move will create 3,000 high-skilled jobs and provide work for approximately 10,000 ...

Eli Lilly & Co has announced a $27-billion expansion of its US manufacturing operations, adding four new sites and creating ...

In this week’s edition of InnovationRx, we look at Eli Lilly’s weight-loss pill stockpiling, scaling stem cell manufacturing, ...

David Ricks said drugs like Mounjaro and Zepbound are priced to reflect the costs involved, patent expiry, and the enormous ...

Over the last few years, as Eli Lilly has revealed a series of manufacturing investments—each one seemingly more lavish than ...

Eli Lilly has lowered the price of its weight-loss drug Zepbound for patients paying out of pocket and introduced two new ...

Drugmaker Eli Lilly plans to invest up to $27 billion to build four new pharmaceutical manufacturing sites in the U.S., the ...

摩根大通近期更新了2025年预计将迎来增长的生物制药公司名单，继续看好Eli Lilly的表现。分析师Chris Scott指出，尽管美国生物制药行业的大型公司在今年的股市表现优于标普500指数，行业估值依旧接近历史低谷。

Pharmaceutical giant Eli Lilly is once again expanding the supply of its weight-loss drug Zepbound and cutting the cost for patients that don't have insurance.

摩根大通更新了一批可能在今年迎来上涨的生物制药公司名单，此前该行业的一些公司经历了一段冷热不均的时期。该机构在该领域的首选股票仍然是Eli Lilly。根据分析师Chris Scott的说法，Gilead Sciences和Bristol Myers ...

Eli Lilly has unveiled a $27 billion (€25.7 billion) investment in US manufacturing facilities as the pharmaceutical industry ...

Eli Lilly ( LLY) announced Wednesday that it is ramping up US manufacturing, adding four new sites to help increase the ...